x

Search for a clinical trial

* (*) mandatory field

81 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

FRANCE

ILE-DE-FRANCE
PARIS

A Phase I, Multi-center, Open-label Study of LEE011 in Patients With Malignant Rhabdoid Tumors and Neuroblastoma - FR
CLCC Institut Curie
Département d'Oncologie pédiatrique, adolescents et jeunes adultes

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

South Yorkshire
SHEFFIELD

BELGIUM

VLAAMS BRABANT
LEUVEN

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma- BE (completed)
University Hospitals Leuven - Gasthuisberg
General medical oncology/Algemene Medische Oncologie

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCE

ILE-DE-FRANCE
VILLEJUIF

TSAR : A Randomized Phase III Trial Comparing Trabectedin (Yondelis®) to the Best Supportive Care in Patients With Advanced Soft Tissue Sarcoma
CLCC Institut Gustave Roussy
Département de Médecine oncologique - Sarcomes et tumeurs mésenchymateuses

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Recruiting trial
Ongoing trial
Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study (Phase II) - FR
CLCC Institut Bergonié
Département d'oncologie médicale - Groupe Sarcomes

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

GERMANY

Nordrhein-Westfalen
MÜNSTER

Doxo: Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - DE - Completed
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

Phase II pharmacokinetic study to assess the age-dependency in the clearance of Doxorubicin in paediatric patients with Solid Tumours and Leukaemia - UK
Northern Institute for Cancer Research, Medical School, Newcastle University
Northern Institute for Cancer Research

Multinational clinical trial(s)